A phase II trial of continuous-infusion recombinant interleukin-2 in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.

Source:http://linkedlifedata.com/resource/pubmed/id/8574465

Download in:

View as

Triples

General Info

PMID
8574465